Investment in Vaxxas winner at 2012 Vaccine Industry Awards
Posted on April 17, 2012 by Jacinta
WASHINGTON, DC, USA and BRISBANE, QUEENSLAND, AUSTRALIA – The $15m syndicated investment in Vaxxas Pty Ltd, developers of the Nanopatch™, a new needle-free vaccine delivery system, was judged the Best Venture Capital Investment at the 2012 Vaccine Industry Excellence Awards, … Continue reading →